Berkshire Hathaway (B), US0846707026

Berkshire Hathaway (B) Stock Faces Recent Pressure Amid Valuation Debate as Book Value Signals Undervaluation

15.03.2026 - 05:21:11 | ad-hoc-news.de

Berkshire Hathaway (B) stock (ISIN: US0846707026) has declined nearly 5% over the past year, trading at levels that analysts view as 39% undervalued relative to its book value growth potential, prompting fresh interest from value investors.

Berkshire Hathaway (B), US0846707026 - Foto: THN

Berkshire Hathaway (B) stock (ISIN: US0846707026), the Class B shares of Warren Buffett's legendary conglomerate, has experienced downward pressure in recent trading sessions as of mid-March 2026. Closing around $492 per share following a volatile week, the stock reflects broader market caution despite robust long-term performance. Investors are weighing the company's intrinsic value against current market dynamics, with recent data highlighting a potential bargain for patient allocators.

As of: 15.03.2026

By Eleanor Voss, Senior Holding Companies Analyst - Berkshire Hathaway (B) stock specialist with a focus on capital allocation strategies for European investors.

Current Market Snapshot Shows Modest Declines

The **Berkshire Hathaway (B)** stock has posted a year-to-date decline of approximately 1.4%, with a 2% drop over the past 30 days and a 1.8% retreat in the last week, trading near $490-$492 levels in early March 2026. Daily volume has hovered around 3-5 million shares, supporting a market capitalization exceeding $1 trillion, underscoring the stock's mega-cap stability. Over five years, shares have surged 136%, far outpacing broader indices, yet short-term sentiment remains tempered.

This pullback coincides with mixed sector rotations, where diversified holdings like Berkshire face scrutiny amid tech-heavy rallies. For European investors accessing the stock via Xetra or other platforms, the liquidity remains strong, though currency fluctuations between USD and EUR add a layer of volatility.

Book Value Model Points to Significant Undervaluation

Analyst models peg Berkshire Hathaway (B) as 39% undervalued, based on a current book value per share of roughly $498,663 and a projected stable value of $545,418, derived from weighted future estimates. The stock's P/E ratio stands at 15.79x, below the diversified financials industry average of 17.57x and peer group at 22.02x, suggesting a fair P/E closer to 17.10x when adjusted for earnings profile and risk. This excess returns valuation framework highlights the conglomerate's potential for superior returns on equity, estimated at a stable EPS of $66,585 per share.

Why does the market care now? With recent share declines, the discount to intrinsic value has widened, attracting value-oriented funds. For DACH investors, familiar with holding company structures like Investor AB or Exor, Berkshire's NAV logic offers a compelling case, especially as eurozone yields remain subdued.

Holding Company Structure Drives Unique Investor Appeal

Berkshire Hathaway operates as a classic **holding company**, with no dividend policy but masterful capital allocation under Warren Buffett's stewardship. Its portfolio spans insurance (Geico, reinsurance), railroads (BNSF), utilities (Berkshire Hathaway Energy), manufacturing, and a massive equity portfolio including Apple, Chevron, and others. Class B shares (ISIN: US0846707026) represent 1/1500th of Class A, providing retail access to the same economic interest at a fraction of the price.

This structure implies investors bet on net asset value (NAV) growth, holding discounts, and buyback discipline rather than yield. Recent data shows steady book value accretion, outpacing share price, which amplifies the undervaluation thesis. European investors, particularly in Switzerland and Germany, appreciate this model akin to HAL Trust or Investor, where governance and allocation trump quarterly beats.

Insurance and Investment Engines Fuel Resilience

Insurance operations remain Berkshire's float generator, funding investments with low-cost capital. Combined ratios and premium growth drive profitability, while the equity portfolio benefits from market exposure without direct management overhead. Recent performance data indicates stable returns, with YTD equity portfolio contributions supporting overall value.

Capital allocation shines through share repurchases when undervalued and bolt-on acquisitions. No major M&A announced in early 2026, but cash pile growth positions Berkshire for opportunities amid market dips. For DACH portfolios, this counter-cyclical approach hedges against eurozone slowdowns, offering USD diversification.

Recent Price Action and Technical Setup

From March 12, 2026, at $491.89 to earlier highs near $497, the stock shows consolidation. Five-day performance flatlines at +0.02%, monthly -1.62%, contrasting 8.54% YTD and 8.37% annual gains. Support levels around $485-$490 align with 50-day moving averages, with resistance at $500.

Volume spikes during declines suggest distribution, but mega-cap status limits downside. Chart patterns indicate potential rebound if book value reports confirm growth.

European and DACH Investor Perspective

For German, Austrian, and Swiss investors, Berkshire Hathaway (B) trades accessibly on Xetra, offering low-cost exposure to US value plays. Amid ECB rate cuts and DAX volatility, the stock's defensive portfolio - railroads, energy, consumer staples - appeals as a ballast. Swiss franc investors value its inflation-hedging via real assets.

Tax-efficient via depot structures, Berkshire sidesteps US estate tax issues for non-residents holding B shares. Compared to European peers like Allianz or Siemens, its pure-play allocation edge stands out, especially with no dividend leakage.

Catalysts, Risks, and Capital Allocation Outlook

Near-term catalysts include Q1 2026 earnings, potential buybacks if discount persists, and portfolio updates on stakes like Chevron. Risks encompass insurance catastrophes, regulatory scrutiny on size, and succession post-Buffett. Balance sheet strength, with massive cash reserves, mitigates downturns.

Outlook favors patient holders, as historical compounding resumes. Analysts maintain buy ratings, citing undervaluation.

Disclaimer: Not investment advice. Stocks are volatile financial instruments.

So schätzen die Börsenprofis Berkshire Hathaway (B) Aktien ein!

<b>So schätzen die Börsenprofis Berkshire Hathaway (B) Aktien ein!</b>
Seit 2005 liefert der Börsenbrief trading-notes verlässliche Anlage-Empfehlungen – dreimal pro Woche, direkt ins Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr. Jetzt abonnieren.
Für. Immer. Kostenlos.
US0846707026 | BERKSHIRE HATHAWAY (B) | boerse | 68683586 | bgmi